secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRUKER CORP (BRKR)
CIK:        0001109354
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0000950170-25-097082
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bruker pre-announces Q2 preliminary EPS $0.32-$0.34, down ~$0.19 YoY
--------------------------------------------------------------------

- Preliminary Q2 2025 revenue $795-$798M, roughly flat YoY reported; constant-currency revenue down ~3%.
- Non-GAAP organic revenue declined ~7% YoY on weak academic demand and soft U.S. biopharma market.
- Non-GAAP EPS expected $0.32-$0.34, down ~$0.19 YoY inclusive of $0.06 FX headwind.
- Q2 2025 bookings reflect weak academic and biopharma demand; cost actions underway.
- Final Q2 results and earnings call scheduled for August 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1109354/000095017025097082/0000950170-25-097082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1109354/000095017025097082/brkr-20250721.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-097082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer